FindMyKOL

Stephen Kirkby, MD

Basic profile

Nationwide Children's Hospital

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionColumbus, OH · MidwestSpecialtyPediatric PulmonologyFocusRespiratory
Active KOLFindMyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Stephen Kirkby is a Respiratory physician affiliated with Nationwide Children's Hospital. OpenAlex indexes 117 publications with 1,342 citations (h-index 19).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
117publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

1,342citations

Citations across these publications.

19h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Actelion Pharmaceuticals US, Inc.
    Program year20231 payment
    $20
  • Actelion Pharmaceuticals US, Inc.
    Program year20221 payment
    $108

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    33.7%
    Proton pump inhibitor12.5%
    Pantoprazole Sodium60%Omeprazole40%
    Part D<11 patients
    Corticosteroid10.3%
    Prednisone100%
    Part D≥12 patients

    + 2 more classes in this area

  • Anti-infectives

    26.7%
    Macrolide Antimicrobial15.4%
    Azithromycin100%
    Part D≥15 patients
    Short-acting sulfonamides11.3%
    Sulfamethoxazole-Trimethoprim100%
    Part D≥11 patients
  • Cardiovascular

    19%
    Beta blocker8.9%
    Carvedilol54%Metoprolol Tartrate46%
    Part D<11 patients
    Statin6.5%
    Rosuvastatin Calcium52%Pravastatin Sodium48%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”